The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study-Reference-Cited by-同舟云学术

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

Published:2017-11-17 Issue:1 Volume:27 Page:59-68
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Daley Matthew F.¹²^ORCID,Clarke Christina L.¹,Glanz Jason M.¹,Xu Stanley¹,Hambidge Simon J.¹²³,Donahue James G.⁴,Nordin James D.⁵,Klein Nicola P.⁶,Jacobsen Steven J.⁷,Naleway Allison L.⁸,Jackson Michael L.⁹,Lee Grace¹⁰,Duffy Jonathan¹¹,Weintraub Eric¹¹

Affiliation:

1. Institute for Health Research; Kaiser Permanente Colorado; Denver CO USA

2. Department of Pediatrics; University of Colorado School of Medicine; Aurora CO USA

3. Community Health Services; Denver Health; Denver CO USA

4. Marshfield Clinic Research Foundation; Marshfield WI USA

5. HealthPartners Institute; Minneapolis MN USA

6. Division of Research; Kaiser Permanente Northern California; Oakland CA USA

7. Department of Research and Evaluation; Kaiser Permanente Southern California; Pasadena CA USA

8. Center for Health Research; Kaiser Permanente Northwest; Portland OR USA

9. Kaiser Permanente Washington Health Research Institute; Seattle WA USA

10. Department of Population Medicine; Harvard Medical School; Boston MA USA

11. Immunization Safety Office; Centers for Disease Control and Prevention; Atlanta GA USA

Funder

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference52 articles.

1. Prevention and control of seasonal influenza with vaccines;Grohskopf;MMWR Recomm Rep,2016

2. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States;Caspard;Vaccine,2016

3. Seasonal effectiveness of live attenuated and inactivated influenza vaccine;Chung;Pediatrics,2016

4. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States;Gaglani;J Infect Dis,2016

5. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results;Pebody;Euro Surveill,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024);Vaccine;2024-10

2. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19

3. Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022–2023 season;Italian Journal of Pediatrics;2024-05-13

4. Assessment of potential adverse events following the 2022–2023 seasonal influenza vaccines among U.S. adults aged 65 years and older;Vaccine;2024-05

5. Analyzing adverse drug reaction using statistical and machine learning methods;Medicine;2022-06-24